Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
Study Outlines Hand Hygiene Guidelines for EVS Staff
McCarthy Completes $65M Sharp Rees-Stealy Kearny Mesa MOB Modernization
Florida Cancer Specialists & Research Institute Opens St. Petersburg Bayfront Location
Healthcare Workers Need Better Workplaces
Protecting Patients Through Design and Compliance at Altru Health System